Article
A loss-of-function polymorphism in ATG16L1 compromises therapeutic outcome in head and neck carcinoma patients.
Oncoimmunology - 1 Jan 2022
Le Naour Julie, Sztupinszki Zsofia, Carbonnier Vincent, Casiraghi Odile, Marty Virginie, Galluzzi Lorenzo, Szallasi Zoltan, Kroemer Guido, Vacchelli Erika
Abstract excerpt
The anticancer immune response is shaped by immunogenic cell stress and death pathways. Thus, cancer cells can release danger-associated molecular patterns that act on pattern recognition receptors expressed by dendritic cells and their precursors to elicit an antitumor immune response. Here, we investigated the impact of single nucleotide polymorphisms (SNPs) in genes affecting this cancer-immunity dialogue in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
